The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model
- PMID: 25889209
- PMCID: PMC4334851
- DOI: 10.1186/s12985-015-0245-0
The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model
Abstract
Aim: The zinc finger antiviral protein (ZAP) is a mammalian host restriction factor, and it could inhibit HBV RNA synthesis in vitro experiments. However, the role of ZAP against HBV in vivo environment is unclear. This study aimed to investigate whether ZAP could act against HBV transcription and replication in ZAP tansgenic mouse model.
Methods: HBV-replication-competent plasmid pHBV4.1 was transferred to ZAP transgenic ICR mouse via the tail vein using a hydrodynamic in vivo transfection procedure, and ICR mouse were used as controls. HBV RNA and HBV DNA replication intermediates in the liver were respectively analyzed by Northern blotting and Southern blotting. The expression of hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg) in the liver tissue was detected by immunohistochemical staining.
Results: As compared to ICR control mouse, the levels of 3.5 kb mRNA in ZAP transgenic mouse were decreased by 8.4%; while the level of HBV DNA replication intermediates was decreased by 82%. In addition, the expression of HBsAg and HBcAg in ZAP transgenic mouse liver were both significantly less than that of ICR control mouse.
Conclusions: Our findings suggest that ZAP could inhibit HBV replication in vivo in mice, which offers a new target for anti-HBV drug development.
Figures



Similar articles
-
Establishment and primary application of a mouse model with hepatitis B virus replication.World J Gastroenterol. 2007 Oct 28;13(40):5324-30. doi: 10.3748/wjg.v13.i40.5324. World J Gastroenterol. 2007. PMID: 17879401 Free PMC article.
-
Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.PLoS Pathog. 2013;9(7):e1003494. doi: 10.1371/journal.ppat.1003494. Epub 2013 Jul 11. PLoS Pathog. 2013. PMID: 23853601 Free PMC article.
-
[A construct competent to support the replication of hepatitis B virus of genotype B].Zhonghua Gan Zang Bing Za Zhi. 2009 Jan;17(1):16-20. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19203445 Chinese.
-
Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.Curr Top Microbiol Immunol. 1996;206:149-73. doi: 10.1007/978-3-642-85208-4_9. Curr Top Microbiol Immunol. 1996. PMID: 8608715 Review.
-
Animal models for the study of HBV replication and its variants.J Clin Virol. 2005 Dec;34 Suppl 1:S54-62. doi: 10.1016/s1386-6532(05)80011-3. J Clin Virol. 2005. PMID: 16461225 Review.
Cited by
-
Intracellular Host Restriction of Hepatitis B Virus Replication.Viruses. 2024 May 11;16(5):764. doi: 10.3390/v16050764. Viruses. 2024. PMID: 38793645 Free PMC article. Review.
-
Medical Advances in Hepatitis D Therapy: Molecular Targets.Int J Mol Sci. 2022 Sep 16;23(18):10817. doi: 10.3390/ijms231810817. Int J Mol Sci. 2022. PMID: 36142728 Free PMC article. Review.
-
Strategies to Inhibit Hepatitis B Virus at the Transcript Level.Viruses. 2021 Jul 9;13(7):1327. doi: 10.3390/v13071327. Viruses. 2021. PMID: 34372533 Free PMC article. Review.
-
Gene-Editing and RNA Interference in Treating Hepatitis B: A Review.Viruses. 2023 Dec 8;15(12):2395. doi: 10.3390/v15122395. Viruses. 2023. PMID: 38140636 Free PMC article. Review.
-
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.Vaccines (Basel). 2017 Sep 1;5(3):24. doi: 10.3390/vaccines5030024. Vaccines (Basel). 2017. PMID: 28862649 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials